Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents

Purpose of review To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease. Recent findings Conjunctivitis is by far the most common ocular manifestation of COVID-19 with viral particles being isolated from tears/secretions of infected individuals. Multiple therapeutic options are being explored across a variety of medication classes with diverse ocular side effects. Summary Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. Video abstract http://links.lww.com/COOP/A36.
Source: Current Opinion in Ophthalmology - Category: Opthalmology Tags: COVID19: Edited by Allen Chiang and Prithvi Mruthyunjaya Source Type: research